Trio Pharmaceuticals, Inc. — Form D
Trio Pharmaceuticals, Inc. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-10. The offering totals $1.7M, of which $1.5M was reported sold. Industry: Other.
Offering
- Filed: 2022-11-10
- Form: D
- Accession: 0001953931-22-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $1.7M
- Amount sold: $1.5M
- Remaining: $164K
- Investors: 6
- Date of first sale: 2022-11-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-464453
Issuer
- Name: Trio Pharmaceuticals, Inc.
- CIK: 0001953931
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 11956 Bernardo Plaza Drive, Suite 160, San Diego, CA, 92128
- Phone: (619) 786-3495
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Reiner Laus | Director | San Diego, CA |
| Reiner Laus | Executive Officer | San Diego, CA |
| Shivarupam Bhowmik | Director | San Diego, CA |
| Shivarupam Bhowmik | Executive Officer | San Diego, CA |
| Jeffrey Friedman | Director | Grass Lake, MI |
Other filings by this issuer (1)
More